About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Kubota Pharmaceutical Holdings Co., Ltd.(4596) Summary

4596
TSE Growth
Kubota Pharmaceutical Holdings Co., Ltd.
46
JPY
0
(0.00%)
May 1, 3:30 pm JST
0.31
USD
May 1, 2:30 am EDT
Result
PTS
outside of trading hours
46.6
May 1, 3:24 pm JST
Summary Chart Historical News Financial Result
PER
PBR
1.93
Yield
ー%
Margin Trading Ratio
Stock Price
May 1, 2025
Opening May 1, 9:00 am
46 JPY 0.32 USD
Previous Close Apr 30
46 JPY 0.32 USD
High May 1, 9:05 am
47 JPY 0.32 USD
Low May 1, 9:00 am
46 JPY 0.31 USD
Volume
320,700
Trading Value
0.02B JPY 0.10M USD
VWAP
46.03 JPY 0.32 USD
Minimum Trading Value
4,600 JPY 31 USD
Market Cap
2.69B JPY 0.02B USD
Number of Trades
45
Liquidity & Number of Trades
As of May 1, 2025
Liquidity
Mid
1-Year Average
130
1-Year High Jul 22, 2024
2,149
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 25, 2025 0 2,515,400
Apr 18, 2025 0 2,373,900
Apr 11, 2025 0 2,426,900
Apr 4, 2025 0 2,659,000
Mar 28, 2025 0 2,558,600
Company Profile
Kubota Pharmaceutical Holdings Co., Ltd. is a venture company focused on developing treatments for eye diseases. The company is currently concentrating on developing corrective glasses for myopia. Drug development projects have been suspended.
Sector
Pharmaceuticals
Kubota Pharmaceutical Holdings Co., Ltd. is committed to developing innovative treatments and medical technologies as an ophthalmic medical solutions company. The company aims to contribute to maintaining and restoring vision for patients with eye diseases by developing and commercializing innovative pharmaceuticals and medical devices. Their main focus is in the medical device field, with emphasis on the "Kubota Glass," a wearable device for myopia control using proprietary active stimulation technology. They are also developing "eyeMO," an ultra-compact OCT for home-based ophthalmic care. In the small molecule compound area, they are advancing the development of emixustat hydrochloride as a treatment for Stargardt disease, based on visual cycle modulation technology. The company is actively pursuing partnership strategies with other companies to expand their pipeline and is also exploring M&A opportunities.